NEW YORK ( TheStreet) -- Value investors do it buying stocks they think have a greater intrinsic value than what they are trading at today.
Momentum investors do it buying stocks that are in uptrends and hanging with them as long as they remain in that uptrend.
Technicians believe that a chart says it all.
There is every kind of investing style out there and yet I believe in combining all of these tools into one big grade and comparing against all the other stocks out there.
My style of investing combines performance, valuation, technical analysis and also knowing where the big picture of the market is at any given time.
The big picture of the market right now continues to favor American, small and midcap stocks and, in particular, stocks that are medical or pharmaceutical related.
(OPK - Get Report)
is one such stock that fits this bill and it is currently ranked the number one stock by my Best Stocks Now!
Opko is a
$3.7 billion midcap company
headquartered in Miami that develops a broad range of pharmaceutical products, diagnostic tests and vaccines.
Already we know this stock has got a lot going for it; it's in the right geographic area (U.S), the right asset class (mid-cap) and the right sector (medical) of the market.
So what about performance? Let's take a look at my Best Stocks Now! app to see how this stock has performed over the years.
Over the last 10 years, even though it has been a bumpy ride, Opko has delivered an average annual return of 36.7% per year while the market delivered 5% per year during the same timeframe.
Over the last five years, again, this stock has been all over the place but overall it has delivered an average of 58.7% to investors while the market has averaged returns of only 11.4%.
Over the last three years, the pace has quickened, and the stock's performance has accelerated. Opko's performance has gotten even better with returns of 69.5% per year all the while the market delivered 13% per year. Over the last 12 months while market is up 19.7%, Opko is up a whopping 182%!